TANG CAPITAL MANAGEMENT LLC - Q1 2016 holdings

$220 Million is the total value of TANG CAPITAL MANAGEMENT LLC's 16 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was - .

 Value Shares↓ Weighting
SRPT NewSAREPTA THERAPEUTICS INC$4,880,000250,000
+100.0%
2.22%
BABA NewALIBABA GROUP HLDG LTDsponsored ads$4,742,00060,000
+100.0%
2.16%
OPK NewOPKO HEALTH INC$3,637,000350,000
+100.0%
1.66%
NKTR NewNEKTAR THERAPEUTICS$3,575,000260,000
+100.0%
1.63%
INFI NewINFINITY PHARMACEUTICALS INC$2,424,000460,000
+100.0%
1.10%
BCRX NewBIOCRYST PHARMACEUTICALS$1,217,000430,000
+100.0%
0.55%
LPCN NewLIPOCINE INC$1,015,000100,000
+100.0%
0.46%
LIFE NewATYR PHARMA INC$749,000190,000
+100.0%
0.34%
RXDX NewIGNYTA INC$271,00040,000
+100.0%
0.12%
CLDX NewCELLDEX THERAPEUTICS INC$189,00050,000
+100.0%
0.09%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HERON THERAPEUTICS INC37Q3 202355.0%
LA JOLLA PHARMACEUTICAL CO34Q2 202237.1%
ROCKET PHARMACEUTICALS INC20Q3 202331.6%
BIOMARIN PHARMACEUTICAL INC18Q3 201712.1%
ODONATE THERAPEUTICS INC17Q4 202169.8%
ANAPTYSBIO INC16Q3 202318.4%
COHERUS BIOSCIENCES INC15Q3 20232.7%
EQUILLIUM INC13Q3 20231.2%
RELMADA THERAPEUTICS INC12Q4 20226.2%
MIRATI THERAPEUTICS INC11Q3 202310.9%

View TANG CAPITAL MANAGEMENT LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
42024-02-14
42024-02-02
42023-12-18
13F-HR2023-11-14
42023-10-13
13F-HR2023-08-14
32023-06-01
42023-06-01

View TANG CAPITAL MANAGEMENT LLC's complete filings history.

Compare quarters

Export TANG CAPITAL MANAGEMENT LLC's holdings